United Kingdom-Based Dechra Plans Boston, Massachusetts, Headquarters Operations
03/20/2026
The company’s new 28,000-square-foot global headquarters, located in the Seaport District, will be designed as a technology-enabled collaboration hub supporting its remote-first operating model. Operations are scheduled to begin by June 2026.
"As a pioneer in life sciences and innovation, Boston represents an exciting new chapter for Dechra," said Jesper Nordengaard, Dechra Chief Executive Officer, who will be based in Boston as part of the transition. "Our new headquarters will serve as a center of gravity for strategic decision-making and purposeful collaboration. The Boston ecosystem strengthens our ability to collaborate across markets, connect with partners and customers, and unlock our full growth potential."
Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company that develops, manufactures, and markets specialized medicines and products for companion animals and livestock. The company focuses on niche and underserved areas of animal health, including endocrinology, dermatology, pain management, and critical care treatments.
"Dechra's decision to locate its global headquarters in Boston underscores Massachusetts' leadership in life sciences and our ability to attract companies at the forefront of innovation. Boston offers a unique combination of talent, industry partnerships, and global connectivity that allows companies to scale and collaborate," noted Massachusetts Economic Development Secretary Eric Paley. "As a state full of caring pet owners, it's especially fitting to welcome a company dedicated to keeping our dogs, cats, and other companions healthy. We're excited to welcome Dechra to Massachusetts and look forward to supporting its work to advance veterinary specialty care and animal health worldwide."
"MassBio is pleased to welcome Dechra to Massachusetts as it establishes its global headquarters in Boston. The Commonwealth's leadership in life sciences is driven by a uniquely collaborative ecosystem that brings together industry, academia, and healthcare to advance innovation," added Kendalle Burlin O'Connell, CEO and President MassBio. "We look forward to Dechra contributing to the region's strength in translational science and helping bring new discoveries closer to real-world impact."
Project Announcements
Pulmuone Foods USA Expands Ayer, Massachusetts, Production Operations
04/13/2026
HF Rubber Expands Topeka, Kansas, Production Operations
04/12/2026
Google Plans Putnam County, West Virginia, Data Center Operations
04/12/2026
Stanley Black & Decker Expands Mission, Texas, Production Operations
04/12/2026
Vertiv Expands Westerville-Ironton, Ohio, Operations
04/12/2026
Blue Sky Innovators Expands Fairfax County, Virginia, Operations
04/12/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026
-
40th Annual Corporate and 22nd Annual Consultant Site Selection Survey Results
Q1 2026